HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pfizer

This article was originally published in The Rose Sheet

Executive Summary

Pfizer: U.S. Consumer Health Care Group sales drop 9% to $248.6 mil. for 1995, Pfizer said Jan. 18. The U.S. unit accounted for 63.2% of Pfizer's worldwide consumer health care sales, which slid 4% "due to increased competition for existing brands" and the impact of the devaluation of the Mexican peso, Pfizer said. "Partly offsetting" those factors was the introduction of Barbasol Pure Silk women's shave line in October ("The Rose Sheet" Jan. 15, Marketing In Brief), the company noted. Pfizer net earnings jumped 21% to $1.57 bil. on a net sales increase of 26% to $10.02 bil...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002460

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel